Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

YEYTUO DIN 02567210

Status: Approved
Holder: GILEAD SCIENCES CANADA INC
Molecule: LENACAPAVIR (LENACAPAVIR SODIUM)
Available to quote

Health Canada record

Active ingredient(s)LENACAPAVIR (LENACAPAVIR SODIUM) 309 MG
Dosage formSolution
RouteSubcutaneous
SchedulePRESCRIPTION
ClassHuman
ATCJ05AX31 LENACAPAVIR
Original market date
Current status date09-Apr-2026
SourceHealth Canada DPD

Establishment licence of the holder

Gilead Sciences Canada Inc — licence 101221, currently licensed, last inspection rating C (2022-09-20).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LENACAPAVIR (LENACAPAVIR SODIUM)

DINProductCompanyFormStrengthStatus
02532468SUNLENCAGILEAD SCIENCES CANADA INCTabletLENACAPAVIR (LENACAPAVIR SODIUM) 300 MGMarketed
02532476SUNLENCAGILEAD SCIENCES CANADA INCSolutionLENACAPAVIR (LENACAPAVIR SODIUM) 309 MGMarketed
02567202YEYTUOGILEAD SCIENCES CANADA INCTabletLENACAPAVIR (LENACAPAVIR SODIUM) 300 MGApproved

Notices of Compliance

NOCDateSubmissionReason
372922026-04-09New Drug Submission (NDS)
Request a quote for YEYTUO

How to read a Canadian DIN record